Biotechnology

Bayer, with new leadership stepping in, deprioritizes women’s health R&D mbayer Fri, 03/24/2023 - 13:19

Seen Better days: Digital therapeutics maker lays off 35% of workforce as losses mount apark Fri, 03/24/2023 - 12:55

Peltz steered PTC through several setbacks and successes, most notably the development of the spinal muscular atrophy drug...

PureTech Health will sell some of its royalty interest in Karuna’s drug, known as KarXT, after its second successful...

Induced pluripotent stem cells offer great therapeutic potential and are a valuable tool for understanding how different...

With chatbots like ChatGPT making a splash, machine learning is playing an increasingly prominent role in our lives. For...

Finch pinches pennies, stretching cash to 2025 after layoffs and trial discontinuation gmasson Fri, 03/24/2023 - 10:36

Neuromodulation device for PTSD treatment from GrayMatters snags FDA nod apark Fri, 03/24/2023 - 10:10

Prof. Huang Qing's group from Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) has...

Series A rounds have been easy to secure in the last few years, but industry watchers say they haven't seen a corresponding...

Hailey-Hailey disease is a rare, inherited condition characterized by patches of blisters appearing mainly in the skin...

SPACs back from brink with NK cell therapy biotech's plans for blank-check merger jwaldron Fri, 03/24/2023 - 08:26

Cash crunches keep Bioasis and Celyad’s feet to the fire as wait for better days continues ntaylor Fri, 03/24/2023 - 06:42

Relmada, reeling from 2 late-phase flops, plots comeback for depression drug ntaylor Fri, 03/24/2023 - 05:52

Chutes & Ladders—Ex-Seagen CEO takes new role less than a year after arrest gmasson Thu, 03/23/2023 - 17:36